New tool aims to help lung cancer patients decide on Post-Surgery treatment
NCT ID NCT05416983
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study observed conversations between 37 lung cancer patients and their doctors to create a shared decision-making tool. The tool is designed to help patients who have had surgery decide whether to pursue additional treatment. Researchers aim to improve patient satisfaction by making sure patients feel involved in the decision.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could create a practical tool to help lung cancer patients and doctors make better-informed decisions about post-surgery treatment.
- What could go wrong
- This is a small, completed observational study focused on tool development, not testing a treatment. The tool may not improve outcomes or be widely adopted.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NON-SMALL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple assessment help older lung cancer patients tolerate chemo better?
- Could lung cancer patients get immunotherapy less often?
- New combo aims to stall lung Cancer's spread
- New tool may help older cancer patients avoid harsh chemo side effects
- DNA vaccine aims to train immune system against lung cancer
- Lung cancer vaccine shows promise in early prevention trial